Log In
Print this Print this

10% human immune globulin (Bivigam)

  Manage Alerts
Collapse Summary General Information
Company Biotest AG
DescriptionPolyspecific IV immune globulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationPrimary immunodeficiency disease (PIDD)
Indication DetailsTreat primary immune deficiency disorders
Regulatory Designation
PartnerKedrion Group S.p.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today